Evidence map›Paper›PMID 41501060›Full record

ArticleNature communications2026

Brain and neural cell type proteomics reveal extracellular matrix proteins enriched in progressive multiple sclerosis.

Henry Wang, Niall M Pollock, Hajar Miranzadeh Mahabadi, Jainilkumar Patel, Eman W Moussa, Jason P Fernandes, William G Branton, Na Zhang, Cameron Elliott, Laura Schmitt and 2 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Henry WangDepartment of Biochemistry, University of Alberta, Edmonton, AB, Canada.ORCID http://orcid.org/0000-0002-5730-1571
Niall M PollockDepartment of Medicine (Neurology), University of Alberta, Edmonton, AB, Canada.
Hajar Miranzadeh MahabadiDepartment of Medicine (Neurology), University of Alberta, Edmonton, AB, Canada.
Jainilkumar PatelDepartment of Biochemistry, University of Alberta, Edmonton, AB, Canada.
Eman W MoussaDepartment of Biochemistry, University of Alberta, Edmonton, AB, Canada.
Jason P FernandesDepartment of Medical Microbiology & Immunology, University of Alberta, Edmonton, AB, Canada.ORCID http://orcid.org/0000-0002-0458-7019
William G BrantonDepartment of Medicine (Neurology), University of Alberta, Edmonton, AB, Canada.ORCID http://orcid.org/0000-0002-3259-2544
Na ZhangDepartment of Mathematics & Statistics, University of Alberta, Edmonton, AB, Canada.
Cameron ElliottDepartment of Surgery, Division of Neurosurgery, University of Alberta, Edmonton, AB, Canada.
Laura SchmittDepartment of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, Canada.
Christopher PowerDepartment of Medicine (Neurology), University of Alberta, Edmonton, AB, Canada.
Olivier JulienDepartment of Biochemistry, University of Alberta, Edmonton, AB, Canada. ojulien@ualberta.ca.ORCID http://orcid.org/0000-0001-7068-7299

Funding

Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada (NSERC Canadian Network for Research and Innovation in Machining Technology) RGPIN-2018-05881
6 · The paper itself

Abstract

Progressive multiple sclerosis (PMS) is an autoimmune demyelinating disease of the central nervous system (CNS) in humans. PMS is defined by neuroinflammation and axonal damage with advancing neurological disabilities, although the underlying molecular mechanisms remain uncertain. To gain insight into the proteomic aspects of PMS, we used mass spectrometry to investigate proteomic profiles and specific protein changes in matched CNS tissues (white matter, cortex, and lesions) from persons with PMS and age/sex-matched other disease controls (ODCs). These studies were examined further using proteomes of primary human neural cell types (e.g., neurons, astrocytes, microglia, oligodendrocyte progenitor cells/OPCs) and CNS tissues from PMS mouse models. Extracellular matrix (ECM) related proteins, including the annexin, S100, and AHNAK protein families, were significantly enriched in PMS white matter, especially within demyelinated lesions compared to ODC tissues. These enriched proteins showed increased abundance in astrocytes, microglia, and OPCs compared to neurons. Annexin, S100, and AHNAK family proteins were also increased in the CNS of the cuprizone and experimental autoimmune encephalitis mouse models. These findings highlight the importance of ECM protein induction in CNS glial cells during PMS while providing potential therapeutic targets for future investigation.

Indexed as

BrainExtracellular Matrix ProteinsMultiple Sclerosis, Chronic ProgressiveNeuronsAnimalsAnnexinsAstrocytesDisease Models, AnimalEncephalomyelitis, Autoimmune, ExperimentalFemaleHumansMaleMiceMice, Inbred C57BLMicrogliaMiddle AgedAnnexinsExtracellular Matrix ProteinsProteomeS100 Proteins

Identifiers

PMID41501060
PMCPMC12877194

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.